SB-265610 | Interleukin Related interleukin-related.com

Product Name :
SB-265610

Search keywords :
SB-265610

drugId :
null

Target Vo:
Interleukin-8 receptors

Target Vo Short Name :
Interleukin-8 receptors

Moa_Name:
Interleukin-8 receptors antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Inflammatory Bowel Diseases

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Moesin Antibody
NLRP3 Antibody
ADRB2 Antibody: ADRB2 Antibody is an unconjugated, approximately 46 kDa, rabbit-derived, anti-ADRB2 polyclonal antibody. ADRB2 Antibody can be used for: WB, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, rabbit background without labeling.

Author: Interleukin Related

Related Posts